by Commetric | May 27, 2022 | Blog
Covid has caused a massive acceleration in the use of telehealth but as the virus winds down, the question of whether or not telehealth will blossom and enjoy widespread adoption remains to be seen. Our analysis found that telehealth players like...
![Immunotherapy in the media [Infographic]](https://commetric.com/wp-content/uploads/2022/05/Immunotherapy.jpg)
by Commetric | May 24, 2022 | Blog
Immuno-oncology has continued to be a priority for Big Pharma even during the heights of the Covid pandemic. Commetric’s infographic looks at the media debate around this rapidly developing field, taking into account key topics, companies, spokespeople,...
by Commetric | May 13, 2022 | Blog
As pharma experiences continued momentum for immuno-oncology treatments, with the current drug development pipeline consisting of thousands of potential therapies and therapy combinations, the media conversation around immuno-oncology is becoming livelier and...
by Commetric | Feb 4, 2022 | Blog
During the pandemic, global health diseases have been discussed in two main ways: as being put on the sidelines because of the immediate threat of Covid, or as being finally treatable thanks to the advances in vaccine science turbocharged by the crisis. Our media...
by Commetric | Jan 11, 2022 | Blog
As COVID-19 has unequally affected many racial and ethnic minority groups, the crisis served as a call to action within the public health community, spurring pharma to pursue actionable efforts toward reversing health inequity. Our media analysis found that the top...
